Coronary endothelial dysfunction in patients with acute-onset idiopathic dilated cardiomyopathy

Journal of the American College of Cardiology

Volumn 32, Issue 1, 1998, Pages 216-224

  Mathier, Michael A ^a   Rose, Geoffrey A ^a   Fifer, Michael A ^a   Miyamoto, Michael I ^a   Dinsmore, Robert E ^a   Castaño, Hugo H ^a   Dec, G William ^a   Palacios, Igor F ^a   Semigran, Marc J ^a  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCHOLINE; ADENOSINE;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; ENDOTHELIUM INJURY; FEMALE; FUNCTIONAL ASSESSMENT; HEART CATHETERIZATION; HEART DILATATION; HEART FAILURE; HEART LEFT VENTRICLE EJECTION FRACTION; HEART MUSCLE BIOPSY; HUMAN; HUMAN CELL; HUMAN TISSUE; MALE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; TREATMENT OUTCOME; VASODILATATION;

ACETYLCHOLINE; ACUTE DISEASE; ADENOSINE; ADOLESCENT; ADULT; AGED; CARDIOMYOPATHY, DILATED; CORONARY CIRCULATION; ENDOTHELIUM, VASCULAR; FEMALE; HEART CATHETERIZATION; HEART FAILURE, CONGESTIVE; HUMANS; INFUSIONS, INTRA-ARTERIAL; LASER-DOPPLER FLOWMETRY; MALE; MIDDLE AGED; STROKE VOLUME; SYSTOLE; VASODILATOR AGENTS; VENTRICULAR FUNCTION, LEFT;

EID: 0032126305     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0735-1097(98)00209-5     Document Type: Article

References (49)

1. Kopecky S.I., Gersh B.J. Dilated cardiomyopathy and myocarditis natural history, etiology, clinical manifestations and management . Curr Prob Cardiol. 12:1987;569-647.
2. Sole M.J., Liu P. Viral myocarditis a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy . J Am Coll Cardiol. 22:(Suppl A):1993;99A-105A.
3. Latif N., Baker C.S., Dunn M.J., Rose M.L., Brady P., Yacoub M.H. Frequency and specificity of antiheart antibodies in patients with dilated cardiomyopathy detected using SDS-PAGE and Western blotting. J Am Coll Cardiol. 22:1993;1378-1384.
4. Keeling P.J., Lukaszyk A., Poloniecki J., et al. A prospective case-control study of antibodies to Coxsackie B virus in idiopathic dilated cardiomyopathy. J Am Coll Cardiol. 23:1994;593-598.
5. Hauck A.J., Kearney D.L., Edwards W.D. Evaluation of postmortem endomyocardial biopsy specimens from 38 patients with lymphocytic myocarditis implications for role of sampling error . Mayo Clin Proc. 64:1989;1235-1245.
6. Unverferth D.V., Magorien R.D., Lewis R.P., Leier C.V. The role of subendocardial ischemia in perpetuating myocardial failure in patients with nonischemic congestive cardiomyopathy. Am Heart J. 105:1983;176-179.
7. Neglia D., Parodi O., Gallopin M., et al. Myocardial blood flow response to pacing tachycardia and to dipyridamole infusion in patients with dilated cardiomyopathy without overt heart failure. Circulation. 92:1995;796-804.
8. Treasure C.B., Vita J.A., Cox D.A., et al. Endothelium-dependent dilation of the coronary microvasculature is impaired in dilated cardiomyopathy. Circulation. 81:1990;772-779.
9. Kubo S.H., Rector T.S., Bank A.J., Williams R.E., Heifetz S.M. Endothelium-dependent vasodilation is attenuated in patients with heart failure. Circulation. 84:1991;1589-1596.
10. Inoue T., Sakai Y., Morooka S., et al. Vasodilatory capacity of coronary resistance vessels in dilated cardiomyopathy. Am Heart J. 127:1994;376-381.
11. Holdright D.R., Clarke D., Fox K., Poole-Wilson P.A., Collins P. The effects of intracoronary substance P and acetylcholine on coronary blood flow in patients with idiopathic dilated cardiomyopathy. Eur Heart J. 15:1994;1537-1544.
12. Mayhan W.G., Rubinstein I. Acetylcholine induces vasoconstriction in the microcirculation of cardiomyopathic hamsters reversal by L-arginine . Biochem Biophys Res Commun. 184:1992;1372-1377.
13. Kiuchi K., Sato N., Shannon R.P., Vatner D.E., Morgan K., Vatner S.F. Depressed beta-adrenergic receptor- and endothelium-mediated vasodilation in conscious dogs with heart failure. Circ Res. 73:1993;1013-1023.
14. Katz S.D., Biasucci L., Sabba C., et al. Impaired endothelium-mediated vasodilation in the peripheral vasculature of patients with congestive heart failure. J Am Coll Cardiol. 19:1992;918-925.
15. Wilson R.F., Laughlin D.E., Ackell P.H., et al. Transluminal, subselective measurement of coronary artery blood flow velocity and vasodilator reserve in man. Circulation. 72:1985;82-92.
16. Sibley D.H., Millar H.D., Hartley C.J., Whitlow P.L. Subselective measurement of coronary blood flow velocity using a steerable Doppler catheter. J Am Coll Cardiol. 8:1986;1332-1340.
17. Ganz W., Tamura K., Marcus H.S., Donoso R., Yoshida S., Swan H.J.C. Measurements of coronary sinus blood flow by continuous thermodilution in man. Circulation. 44:1971;181-195.
18. Cox D.A., Vita J.A., Treasure C.B., et al. Atherosclerosis impairs flow-mediated dilation of coronary arteries in humans. Circulation. 80:1989;458-465.
19. Haase J., Di M.C., Slager C.J., et al. In-vivo validation of on-line and off-line geometric coronary measurements using insertion of stenosis phantoms in porcine coronary arteries. Cathet Cardiovasc Diagn. 27:1992;16-27.
20. Reiber J.H., Serruys P.W., Kooijman C.J., et al. Assessment of short-, medium-, and long-term variations in arterial dimensions from computer-assisted quantitation of coronary cineangiograms. Circulation. 71:1985;280-288.
21. Aretz H.T., Billingham M.E., Edwards W.D., et al. Myocarditis a histopathologic definition and classification . Am J Cardiovasc Pathol. 1:1986;3-14.
22. Vita J.A., Treasure C.B., Nabel E.G., et al. Coronary vasomotor response to acetylcholine relates to risk factors for coronary artery disease. Circulation. 81:1990;491-497.
23. Reddy K.G., Nair R.N., Sheehan H.M., Hodgson J.M. Evidence that selective endothelial dysfunction may occur in the absence of angiographic or ultrasound atherosclerosis in patients with risk factors for atherosclerosis. J Am Coll Cardiol. 23:1994;833-843.
24. Ludmer P.L., Selwyn A.P., Shook T.L., et al. Paradoxical vasoconstriction induced by acetylcholine in atherosclerotic coronary arteries. N Engl J Med. 315:1986;1046-1051.
25. Nitenberg A., Antony I., Foult J.M. Acetylcholine-induced coronary vasoconstriction in young heavy smokers with normal coronary arteriographic findings. Am J Med. 95:1993;71-77.
26. Luscher T.F., Vanhoutte P.M. Endothelium-dependent contractions to acetylcholine in the aorta of the spontaneously hypertensive rat. Hypertension. 8:1986;344-348.
27. Torres F.W., Acquatella H., Condado J.A., Dinsmore R., Palacios I.F. Coronary vascular reactivity is abnormal in patients with Chagas' heart disease. Am Heart J. 129:1995;995-1001.
28. Luscher T.F., Boulanger C.M., Dohi Y., Yang Z. Endothelium-derived contracting factors. Hypertension. 19:1992;117-130.
29. Furchgott R.F., Zawadzki J.V. The obligatory role of endothelial cells in the relaxation of arterial smooth muscle by acetylcholine. Nature. 288:1980;373-376.
30. Arbustini E., Grasso M., Diegoli M., et al. Morphologic changes induced by acetylcholine infusion in normal and atherosclerotic coronary arteries. Am J Cardiol. 71:1993;1382-1390.
31. Friedman H.M., Macarak E.J., MacGregor R.R., Wolfe J., Kefalides N.A. Virus infection of endothelial cells. J Infect Dis. 143:1981;266-273.
32. Hengstenberg C., Rose M.L., Olsen E.G.J., Maisch B. Immune response to the endothelium in myocarditis, dilated cardiomyopathy, and rejection after heart transplantation. Eur Heart J. 12:(Suppl D):1991;144-146.
33. Morris S.A., Bilezikian J.P., Hatcher V., Weiss L.M. Trypanosoma cruzi infection of cultured human endothelial cells alters inositol phosphate synthesis . Exp Parasitol. 69:1989;330-339.
34. Morris S.A., Wittner N., Weiss L., et al. Extracellular matrix derived from Trypanosoma cruzi infected endothelial cells directs phenotypic expression. J Cell Physiol. 145:1990;340-346.
35. Tarnawski A., Stachura J., Gergely H., Hollander D. Microvascular endothelium - a major target for alcohol injury of the human gastric mucosa. J Clin Gastroenterol. 10:(Suppl 1):1988;S53-S64.
36. Factor S.M., Minase T., Cho S., Dominitz R., Sonnenblick E.H. Microvascular spasm in the cardiomyopathic Syrian hamster a preventable cause of focal myocardial necrosis . Circulation. 66:1982;342-354.
37. Factor S.M., Cho S., Wittner M., Tanowitz H.B. Abnormalities of the coronary microcirculation in acute murine Chagas' disease. Am J Trop Med Hyg. 34:1985;246-253.
38. Factor S.M., Cho S., Scheuer J., Sonnenblick E.H., Malhotra A. Prevention of hereditary cardiomyopathy in the Syrian hamster with chronic verapamil therapy. J Am Coll Cardiol. 12:1988;1599-1604.
39. Treasure C.B., Klein J.L., Vita J.A., et al. Hypertension and left ventricular hypertrophy are associated with impaired endothelium-mediated relaxation in human coronary resistance vessels. Circulation. 87:1993;86-93.
40. Panza J.A., Quyyumi A.A., Brush J.E., Epstein S.E. Abnormal endothelium-dependent vascular relaxation in patients with essential hypertension. N Engl J Med. 323:1990;22-27.
41. Hatake K., Wakabayashi I., Kakishita E., et al. Inhibitory effect of ethanol on endothelium-dependent vascular responsiveness. Eur J Pharmacol. 168:1989;277-283.
42. Davda R.K., Chandler L.J., Crews F.T., Guzman N.J. Ethanol enhances the endothelial nitric oxide synthase response to agonists. Hypertension. 21:1993;939-943.
43. Dec G.W., Palacios I.F., Fallon J.T., et al. Active myocarditis in the spectrum of acute dilated cardiomyopathies. N Engl J Med. 312:1985;885-890.
44. Steimle A.E., Stevenson L.W., Fonarow G.C., Hamilton M.A., Moriguchi J.D. Prediction of improvement in recent onset dilated cardiomyopathy after referral for heart transplantation. J Am Coll Cardiol. 23:1994;553-559.
45. Figulla H.R., Rahlf G., Nieger M., Luig H., Kreuzer H. Spontaneous hemodynamic improvement or stabilization and associated biopsy findings in patients with congestive cardiomyopathy. Circulation. 71:1985;1095-1104.
46. Foult J.-M., Tavolaro O., Antony I., Nitenberg A. Direct myocardial and coronary effects of enalaprilat in patients with dilated cardiomyopathy assessment by a bilateral intracoronary infusion technique . Circulation. 77:1988;337-344.
47. Magorien R.D., Brown G.P., Unverferth D.V., et al. Effects of hydralazine on coronary blood flow and myocardial energetics in congestive heart failure. Circulation. 65:1982;528-533.
48. Kiowski W., Erne P., Pfisterer M., Mueller J., Buehler F.R., Burkart F. Arterial vasodilator, systemic and coronary hemodynamic effects of nisoldipine in congestive heart failure secondary to ischemic or dilated cardiomyopathy. Am J Cardiol. 59:1987;1118-1125.
49. Teerlink J.R., Clozel M., Fischli W., Clozel J.-P. Temporal evolution of endothelial dysfunction in a rat model of chronic heart failure. J Am Coll Cardiol. 22:1993;615-620.